A Class II Special Controls Guideline about John Cunningham Virus Serological Reagents has recently been posted. This document was developed to support the classification of the John Cunningham Virus (JCV) serological reagents for the risk stratification for progressive multifocal leukoencephalopathy (PML) development into class II (special controls).
MRSA Prevention Toolkit: Targeting SSI
Hace 13 horas
No hay comentarios:
Publicar un comentario